| ORPN - Bioblast Pharma Ltd (Healthcare: Biotechnology) | Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-03-27) |
|
|
|||||||||||||||||
|
|
|
| Company Profile | |
| Bioblast Pharma Ltd is an Israel-based development-stage biopharmaceutical company. The firm is focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases. It focuses on therapeutic platforms that offer solutions for several diseases that share a common pathophysiological mechanism, which are the functional changes that accompany a particular syndrome or disease. It also focuses on diseases with severe and debilitating manifestations. | |
| Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. |